Is type II diabetes mellitus a disease of the innate immune system?

Diabetologia

Volumn 41, Issue 10, 1998, Pages 1241-1248

  Pickup, J C ^a   Crook, M A ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

Acute phase response; Cytokines; Innate immune system; Interleukins

Indexed keywords

ACUTE PHASE PROTEIN; AMYLOID A PROTEIN; BRAIN PEPTIDE; C REACTIVE PROTEIN; CYTOKINE; GLUCOSE; GLYCOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HORMONE; HYDROCORTISONE; INSULIN; INTERLEUKIN 6; LIPOPROTEIN; OROSOMUCOID; SIALIC ACID;

ACUTE PHASE RESPONSE; ATHEROSCLEROSIS; CLINICAL FEATURE; HUMAN; HYPERTRIGLYCERIDEMIA; IMMUNE SYSTEM; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; REVIEW; STRESS;

ACUTE-PHASE REACTION; ANIMALS; CYTOKINES; DIABETES MELLITUS, TYPE 2; HUMANS; IMMUNITY; MODELS, BIOLOGICAL;

EID: 0031720795     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051058     Document Type: Review

References (86)

1. Reaven GM (1988) Role of insulin resistance in human disease. Diabetes 37: 1595-1607
2. Wajchenberg BL, Malerbi DA, Rocha MS, Lerario AC, Santamauro ATMG (1994) Syndrome X: a syndrome of insulin resistance. Diabetes Metab Rev 10: 19-29
3. Kushner I, Rzewnicki DL (1994) The acute phase response: general aspects. Bailliere's Clin Rheumatol 8: 513-530
4. Fearon DT, Locksley RM (1996) The instructive role of innate immunity in the acquired immune response. Science 272: 50-54
5. Medzhitov R, Janeway CA (1997) Innate immunity: impact on the adaptive immune response. Curr Opin Immunol 9: 4-9
6. Pearson AM (1996) Scavenger receptors in innate immunity. Curr Opin Immunol 8: 20-28
7. Ibrahim MAA, Chain BM, Katz DR (1995) The injured cell: the role of the dendritic cell system as a sentinel receptor pathway. Immunol Today 16: 181-186
8. Baumann H, Gauldie J (1994) The acute phase response. Immunol Today 15: 74-80
9. Steel DM, Whitehead AS (1994) The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today 15: 81-87
10. Taniuchi K, Chifu K, Hayashi N et al. (1981) A new enzymatic method for the determination of sialic acid and its application as a marker of acute phase reactants Kobe J Med Sci 27: 91-102
11. Kushner I (1993) Regulation of the acute phase response by cytokines. Perspect Biol Med 36: 611-622
12. Olsson AG (1991) Non-atherosclerotic disease and lipoproteins. Curr Opin Lipidol 2: 206-210
13. Spiegel R, Schaffer EJ, Magrath IT, Edwards BK (1982) Plasma lipid alterations in leukemia and lymphoma. Am J Med 72: 775-782
14. Blackman JD, Cabana VG, Mazzone T (1993) The acute-phase response and associated lipoprotein abnormalities accompanying lymphoma. J Intern Med 233: 201-204
15. Cabana VG, Siegel JN, Sabesin SM (1989) Effects of the acute phase response on the concentration and density distribution of plasma lipids and apoliproteins. J Lipid Res 30: 39-49
16. Ganrot PO, Gydelli K, Ekelund H (1967) Serum concentration of α-2 macroglobulin, haptoglobin and α-1 antitrypsin in diabetes mellitus. Acta Endocr 55: 537-544
17. Jonsson A, Wales JK (1976) Blood glycoprotein levels in diabetes mellitus. Diabetologia 12: 245-250
18. McMillan DE (1989) Increased levels of acute-phase serum proteins in diabetes. Metabolism 38: 1042-1046
19. Crook M, Tutt P, Pickup JC (1993) Elevated serum sialic acid concentration in non-insulin-dependent diabetes and its relationship to blood pressure and retinopathy. Diabetes Care 16: 57-60
20. Crook MA, Tutt P, Simpson H, Pickup JC (1993) Serum sialic acid and acute phase proteins in type 1 and 2 diabetes. Clin Chim Acta 219: 131-138
21. Pickup JC, Mattock MB, Chusney GD, Burt D (1997) NIDDM as a disease of the innate immune system: association of acute phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 40: 1286-1292
22. Ganda OM, Arkin CF (1992) Hyperfibrinogenemia: an important risk factor for vascular complications in diabetes. Diabetes Care 15: 1245-1250
23. Kannel WB, D'Argostino RB, Wilson PWF, Belanger AJ, Gagnon DR (1990) Diabetes, fibrinogen, and risk of cardiovascular disease: the Framingham experience. Am Heart J 120: 672-676
24. Figueredo A, Ibarra JL, Bagazgoitia J et al (1993) Plasma C3d levels and ischemic heart disease in type II diabetes. Diabetes Care 16: 445-449
25. Yudkin J (1995) Coronary heart disease in diabetes mellitus: three new risk factors and a unifying hypothesis. J Intern Med 238: 21-30
26. Pickup JC, Mattock MB, Crook MA, Chusney GD, Burt D, Fitzgerald AP (1995) Serum sialic acid concentration and coronary heart disease in NIDDM. Diabetes Care 18: 1100-1103
27. Watts GF, Gwilym RM, Makurkiewicz J, Coltart J (1995) Independent correlation between plasma lipoprotein(a) and angiographic coronary artery disease in NIDDM. Diabetes Care 18: 234-236
28. Maeda S, Abe A, Makino K, Kawade M (1989) Transient changes in serum lipoprotein(a) as an acute phase reactant. Atherosclerosis 879: 145-150
29. Dinarello CA (1991) Interleukin-1. In: Thomson AW (ed) The Cytokine Handbook. Academic Press, London, pp 47-82
30. Akira S, Taga T, Kishimoto T (1993)1 Interleukin-6 in biology and medicine. Adv Immunol 54: 1-78
31. Jaattela M (1991) Biological activities and mechanisms of action of tumor necrosis factor α/cachetin. Lab Invest 64: 724-742
32. Feingold KR, Grunfeld C (1992) Role of cytokines in inducing hyperlipidemia. Diabetes 41 [Suppl 2] 97-101
33. Vassilopoulou-Sellin R (1994) Endocrine effects of cytokines. Oncology 8: 43-46
34. Mantovani A, Bussolino F, Dejana E (1992) Cytokine regulation of endothelial cell function. FASEB J 6: 2591-2599
35. Mantovani A, Bussolino F, Intrano M (1997) Cytokine regulation of endothelial cell function: from molecular level to the bedside Immunol Today 18: 231-240
36. Hotamisligil GS, Spiegelman BM (1994) Tumor necrosis factor α: a key component of the obesity-diabetes link. Diabetes 43: 1271-1278
37. Bendtzen K, Buschard K, Diamant M, Horn T, Svenson M (1989) Possible role of IL-1, TNFα and IL-6 in insulin-dependent diabetes mellitus and autoimmune thyroid disease. Lymphokine Res 8: 335-341
38. Rabinovitch A (1994) Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Diabetes 43: 613-621
39. Wang Y, Goodman M, Lumerman J et al. (1989) In vivo administration of interleukin-1 inhibits glucose-stimulated insulin release. Diabetes Res Clin Pract 7: 205-211
40. Rivier C, Vale W (1984) Influence of corticotrophin-releasing factor on reproductive function in the rat. Endocrinol 114: 914-921
41. Barrett-Connor E (1992) Lower endogenous androgen levels and dyslipidemia in men with non-insulin-dependent diabetes. Ann Intern Med 117: 807-811
42. Chrousos GP, Gold PW (1992) The concept of stress and stress system disorders. JAMA 267: 1244-1252
43. Sternberg EM, Chrousos GP, Wilder RL, Gold PW (1992) The stress response and the regulation of inflammatory disease. Ann Intern Med 117: 854-866
44. Herbert J (1997) Stress, the brain and mental illness. BMJ 315: 530-535
45. Gavard JA, Lustman PJ, Clouse RE (1993) Prevalence of depression in adults with diabetes. Diabetes Care 16: 1167-1178
46. Eaton WW, Armenian H, Gallo J, Pratt L, Ford DE (1996) Depression and risk of onset of type II diabetes. Diabetes Care 19: 1097-1102
47. Utsumi A, Suzuki S, Sato Y, Hongo M (1996) Insulin resistance in patients with depression. Diabetes 45 [Suppl 2] 177A
48. Tomasczuk A, Simpson C, Williams G (1996) Neuropeptide Y. the hypothalamus and the regulation of energy homeostasis. Horm Res 46: 53-58
49. Sjogren A, Floren CH, Nilsson A (1988) Magnesium, potassium and zinc deficiency in subjects with type II diabetes. Acta Med Scand 224: 461-465
50. Grunfeld C, Zhao C, Fuller J et al. (1996) Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. J Clin Invest 97: 2152-2157
51. Bornstein SR (1997) Is leptin a stress related peptide? Nature Med 1997; 3: 937
52. Pickup JC, Roberts GA, Kehely AM, Pasapula C, Chusney GD, Mather HM (1997) Higher serum sialic acid in women than in men with NIDDM: possible relevance to increased cardiovascular risk in NIDDM women. Diabetes Care 20: 1496
53. Stuart J, George AG, Davies AJ, Auklund A, Hurlow RA (1981) Haematological stress syndrome in atherosclerosis. J Clin Pathol 34: 464-467
54. Lindberg G, Eklund G, Gullberg B, Rastam L (1991) Serum sialic acid concentration and cardiovascular mortality. BMJ 302: 143-146
55. Haverkate F, Thompson SG, Pyke SDM et al. (1997) Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet 349: 462-466
56. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH (1997) Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336: 973-979
57. Yokoto T, Hannson GK (1995) Immunological mechanisms in atherosclerosis. J Intern Med 238: 479-489
58. Grimble RF (1990) Nutrition and cytokine action. Nutr Res Rev 3: 193-210
59. Endres S, Ghorbani R, Kelly Vet al. (1989) The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumour necrosis factor by mononuclear cells. N Engl J Mod 320: 265-271
60. Raheja BS, Sadikot SM, Phatak RB, Rao MB (1993) Significance of the n-3/n-6 ratio for insulin action in diabetes. Ann N Y Acad Sci 683: 258-271
61. Fagiolo U, Cossarizza A, Scala E et al. (1993) Increased cytokine production in mononuclear cells of healthy elderly people. Eur J Immunol 23: 2375-2378
62. Caswell M, Pike LA, Bull BS, Stuart J (1993) Effect of age on tests of the acute-phase response. Arch Pathol Lab Med 117: 906-910
63. Pickup JC, Day CD, Bailey C et al. (1995) Plasma sialic acid in animal models of diabetes mellitus: evidence for modulation of sialic acid concentrations by insulin deficiency. Life Sci 57: 1383-1391
64. Thompson D, Harrison SP, Evans SW, Whicher JT (1991) Insulin modulation of acute phase protein production in a human hepatoma cell line. Cytokine 3: 619-626
65. Campos SP, Baumann H (1992) Insulin is a prominent modulator of the cytokine-stimulated expression of acute-phase plasma protein genes. Mol Cell Biol 12: 1789-1797
66. Tessari P, Lori E, Vettore M et al. (1997) Evidence for acute stimulation of fibrinogen production by glucagon in humans. Diabetes 46: 1369-1371
67. Morohoshi M, Fujisawa K, Uchimura I, Numano F (1996) Glusose-dependent interleukin-6 and tumor necrosis factor production by human peripheral blood monocytes in vitro. Diabetes 45: 954-959
68. Vlassara H, Brownlee M, Montague KR, Dinarello C, Pasagian A (1988) Cachectin/TNF and IL-1 induced by glucose modified proteins: role in normal tissue modelling. Science 240: 1546-1548
69. Pickup JC, Chana T, Mattock MB, Samuel A, Mather HM (1996) Serum sialic acid concentrations in Asian diabetic patients in the UK. Diabetic Med 13: 284-285
70. Mather HM, Keen H (1985) The Southall diabetes survey: prevalence of known diabetes in Asians and Europeans. BMJ 291: 1081-1084
71. Patel P, Mendall MA, Carrington D et al. (1995) Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ 311: 711-714
72. Cook PJ, Lip GYH (1996) Infectious agents and atherosclerotic vascular disease. Q J Med 89: 727-735
73. Mattila KJ, Nieminen MS, Valtonen VV (1988) Association between dental health and acute myocardial infarction. BMJ 298: 779-782
74. Gupta S, Camm AJ (1997) Chlamydia pneumoniae and coronary heart disease. BMJ 314: 1778-1779
75. Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC (1996) C-reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ 312: 1061-1065
76. Miettinen H, Lebto S, Saikku P et al. (1996) Association of Chlamydia pneumonia and acute coronary heart disease events in non-insulin-dependent diabetic and non-diabetic subjects in Finland. Eur Heart J 17: 682-688
77. Crook MA, Earle K, Morocutti A, Yip J, Viberti GC, Pickup JC (1994) Serum sialic acid, a risk factor for cardiovascular disease, is increased in IDDM patients with microalbuminuria and clinical proteinuria. Diabetes Care 17: 305-310
78. Kushner I, Mackiewicz A (1993) The acute phase response: an overview. In: Mackiewicz A, Kushner I, Baumann H (eds) Acute phase proteins in molecular biology, biochemistry and clinical applications. CRC Press, Boca Raton, pp 3-19
79. Ventre J, Doebber T, Wu M et al. (1997) Targetted disruption of the tumor necrosis factor-α gene. Metabolic consequences in obese and nonobese mice. Diabetes 46: 1526-1531
80. Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS (1997) Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 389: 610-614
81. McNiff PA, Laliberte RE, Svensson L, Pazoles CJ, Gabel CA (1995) Inhibition of cytokine activation processes in vitro by tenidap, a novel anti-inflammatory agent. Cytokine 7: 196-208
82. Chernoff AE, Granowitz EV, Shapiro L et al. (1995) A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses. J Immunol 154: 5492-5499
83. Hales CN, Desai M, Ozanne SE (1997) The thrifty phenotype hypothesis: how does it look after 5 years? Diabet Med 14: 189-195
84. Phillips DIW, Barker DJP, Fall CHD, Whorwood CB, Walker BR, Wood PJ (1997) Low birthweight and raised plasma cortisol concentrations in adult life. Diabet Med 14 [Suppl 1] 11
85. Barker DJP (1995) Fetal origins of coronary heart disease. BMJ 311: 171-174
86. Miles JM (1993) Lipid fuel metabolism in health and disease. Curr Opin Gen Surg 78-84